Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Receives Innovative Technology Contract from Vizient for SurgiMend® Collagen Matrix for Soft Tissue Reconstruction
Contract awarded for products that bring improvement to healthcare industry PRINCETON, N.J., July 14, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, announced its SurgiMend ® Collagen Matrix for Soft Tissue
View HTML
Toggle Summary Integra LifeSciences to Host Second Quarter 2021 Financial Results Conference Call on July 28, 2021
PRINCETON, N.J., July 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2021 financial results on Wednesday, July 28, 2021 prior to market open.
View HTML
Toggle Summary Integra LifeSciences Announces CEO Succession Plan
Peter Arduini to serve as President and CEO through the end of 2021 Candidate search launched to identify successor PRINCETON, N.J., June 24, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced that Peter
View HTML
Toggle Summary Integra LifeSciences Hosts Virtual Investor Day
PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:30 p.m. ET, today May 20, 2021.
View HTML
Toggle Summary Integra LifeSciences to Host Virtual Investor Day on May 20, 2021
PRINCETON, N.J., May 07, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:30 p.m., U.S. eastern time on May 20, 2021.
View HTML
Toggle Summary Integra LifeSciences Reports First Quarter 2021 Financial Results
PRINCETON, N.J., April 28, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2021. First Quarter 2021 Financial Summary Reported revenues were $360.1
View HTML
Toggle Summary Integra LifeSciences Statement on the U.S. FDA Safety Communication on Acellular Dermal Matrix (ADM) Products Used in Implant-Based Breast Reconstruction
PRINCETON, N.J., April 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company and manufacturer of SurgiMend Collagen Matrix, today issued the following statement regarding the U.S.
View HTML
Toggle Summary Integra LifeSciences to Host First Quarter 2021 Financial Results Conference Call on April 28, 2021
PRINCETON, N.J., April 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2021 financial results on Wednesday, April 28, 2021 prior to market open.
View HTML
Toggle Summary Integra LifeSciences Appoints Shaundra Clay as Director
PRINCETON, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Shaundra Clay to its board of directors, effective today. “We are delighted to welcome Shaundra, a seasoned
View HTML
Toggle Summary Integra LifeSciences Announces Participation in Upcoming Investor Conferences
PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that it is participating in the following investor conferences: On February 24, 2021, Carrie Anderson, executive vice president
View HTML